EUVIMEDEUVIMED entdecken
Crossref

A “Ferroptosis-Amplifier” Hydrogel for Eliminating Refractory Cancer Stem Cells Post-lumpectomy

Yutong Zhu, Xi Deng, Zideng Dai, Qing Liu, Yichen Kuang, Tianzhi Liu iD, Hangrong Chen iD

Nano Letters · 2024

DOI: 10.1021/acs.nanolett.4c02192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2024. Verfasst von Yutong Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of High Performance Ceramics and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shangha…. Hauptthemen laut MEDLINE: Neoplastic Stem Cells, Hydrogels, Breast Neoplasms, Ferroptosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Shanghai Municipal People's Government, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The unique "Iron Addiction" feature of cancer stem cells (CSCs) with tumorigenicity and plasticity generally contributes to the tumor recurrence and metastasis after a lumpectomy. Herein, a novel "Ferroptosis Amplification" strategy is developed based on integrating gallic acid-modified FeOOH (GFP) and gallocyanine into Pluronic F-127 (F127) and carboxylated chitosan (CC)-based hydrogel for CSCs eradication. This "Ferroptosis Amplifier" hydrogel is thermally sensitive and achieves rapid gelation at the postsurgical wound in a breast tumor model. Specifically, gallocyanine, as the Dickkopf-1 (DKK1) inhibitor, can decrease the expression of SLC7A11 and GPX4 and synergistically induce ferroptosis of CSCs with GFP. Encouragingly, it is found that this combination suppresses the migratory and invasive capability of cancer cells via the downregulation of matrix metalloproteinase 7 (MMP7). The in vivo results further confirm that this "Ferroptosis Amplification" strategy is efficient in preventing tumor relapse and lung metastasis, manifesting an effective and promising postsurgical treatment for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Stem CellsHydrogelsBreast NeoplasmsFerroptosisHumansAnimalsFemaleMiceCell Line, TumorPoloxamerChitosanGallic Acid

Stichwörter der Autor:innen

antimetastasisbreast cancer stem cellsferroptosisiron oxyhydroxidepostsurgical recurrence

Substanzen

HydrogelsPoloxamerChitosanGallic Acid

Autor:innen und Institutionen

  • State Key Laboratory of High Performance Ceramics and Superfine Microstructures, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, P.R. China.
  • Center of Materials Science and Optoelectronics Engineering, University of Chinese Academy of Sciences, Beijing 100049, P. R. China.
  • School of Chemistry and Materials Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, P. R. China.

ORCID-Profile: Tianzhi Liu, Hangrong Chen

Förderung

  • National Key Research and Development Program of China
  • Shanghai Municipal People's Government
  • Science and Technology Commission of Shanghai Municipality
  • National Natural Science Foundation of China
  • Shanghai Municipality

Zitieren

APA

Zhu, Y., Deng, X., Dai, Z., Liu, Q., Kuang, Y., Liu, T., & Chen, H. (2024). A “Ferroptosis-Amplifier” Hydrogel for Eliminating Refractory Cancer Stem Cells Post-lumpectomy. Nano Letters. https://doi.org/10.1021/acs.nanolett.4c02192

Vancouver

Zhu Y, Deng X, Dai Z, Liu Q, Kuang Y, Liu T, et al. A “Ferroptosis-Amplifier” Hydrogel for Eliminating Refractory Cancer Stem Cells Post-lumpectomy. Nano Letters. 2024. doi:10.1021/acs.nanolett.4c02192

BibTeX
@article{Zhu2024,
  author = {Zhu, Yutong and Deng, Xi and Dai, Zideng and Liu, Qing and Kuang, Yichen and Liu, Tianzhi and Chen, Hangrong},
  title = {A “Ferroptosis-Amplifier” Hydrogel for Eliminating Refractory Cancer Stem Cells Post-lumpectomy},
  journal = {Nano Letters},
  year = {2024},
  doi = {10.1021/acs.nanolett.4c02192}
}
Kostenlos starten →